EPCAM and neoplasm: Meanwhile, in analyses of TGF-β expression in tumor models in vivo, the combination of the EpCAM CAR T cells and hsBCL9CT-24 exhibited the lowest level, significantly reduced compared to the group of EpCAM CAR T cells alone without hsBCL9CT-24 treatment.